Literature DB >> 25754084

The impact of chronic stress on the rat brain lipidome.

T G Oliveira1,2, R B Chan3,4, F V Bravo1,2, A Miranda1,2, R R Silva1,2, B Zhou3,4, F Marques1,2, V Pinto1,2, J J Cerqueira1,2, G Di Paolo3,4, N Sousa1,2.   

Abstract

Chronic stress is a major risk factor for several human disorders that affect modern societies. The brain is a key target of chronic stress. In fact, there is growing evidence indicating that exposure to stress affects learning and memory, decision making and emotional responses, and may even predispose for pathological processes, such as Alzheimer's disease and depression. Lipids are a major constituent of the brain and specifically signaling lipids have been shown to regulate brain function. Here, we used a mass spectrometry-based lipidomic approach to evaluate the impact of a chronic unpredictable stress (CUS) paradigm on the rat brain in a region-specific manner. We found that the prefrontal cortex (PFC) was the area with the highest degree of changes induced by chronic stress. Although the hippocampus presented relevant lipidomic changes, the amygdala and, to a greater extent, the cerebellum presented few lipid changes upon chronic stress exposure. The sphingolipid and phospholipid metabolism were profoundly affected, showing an increase in ceramide (Cer) and a decrease in sphingomyelin (SM) and dihydrosphingomyelin (dhSM) levels, and a decrease in phosphatidylethanolamine (PE) and ether phosphatidylcholine (PCe) and increase in lysophosphatidylethanolamine (LPE) levels, respectively. Furthermore, the fatty-acyl profile of phospholipids and diacylglycerol revealed that chronic stressed rats had higher 38 carbon(38C)-lipid levels in the hippocampus and reduced 36C-lipid levels in the PFC. Finally, lysophosphatidylcholine (LPC) levels in the PFC were found to be correlated with blood corticosterone (CORT) levels. In summary, lipidomic profiling of the effect of chronic stress allowed the identification of dysregulated lipid pathways, revealing putative targets for pharmacological intervention that may potentially be used to modulate stress-induced deficits.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25754084      PMCID: PMC4565780          DOI: 10.1038/mp.2015.14

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  53 in total

1.  Lipidomics: new tools and applications.

Authors:  Markus R Wenk
Journal:  Cell       Date:  2010-12-10       Impact factor: 41.582

2.  Role of prefrontal cortical calcium independent phospholipase A₂ in antidepressant-like effect of maprotiline.

Authors:  Lynette Hui-Wen Lee; Chay-Hoon Tan; Guanghou Shui; Markus R Wenk; Wei-Yi Ong
Journal:  Int J Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 5.176

3.  The amyloidogenic potential and behavioral correlates of stress.

Authors:  C Catania; I Sotiropoulos; R Silva; C Onofri; K C Breen; N Sousa; O F X Almeida
Journal:  Mol Psychiatry       Date:  2007-10-02       Impact factor: 15.992

Review 4.  Stress, memory and the amygdala.

Authors:  Benno Roozendaal; Bruce S McEwen; Sumantra Chattarji
Journal:  Nat Rev Neurosci       Date:  2009-06       Impact factor: 34.870

Review 5.  Effects of stress throughout the lifespan on the brain, behaviour and cognition.

Authors:  Sonia J Lupien; Bruce S McEwen; Megan R Gunnar; Christine Heim
Journal:  Nat Rev Neurosci       Date:  2009-04-29       Impact factor: 34.870

6.  Chronic stress causes frontostriatal reorganization and affects decision-making.

Authors:  Eduardo Dias-Ferreira; João C Sousa; Irene Melo; Pedro Morgado; Ana R Mesquita; João J Cerqueira; Rui M Costa; Nuno Sousa
Journal:  Science       Date:  2009-07-31       Impact factor: 47.728

Review 7.  The ceramide system as a novel antidepressant target.

Authors:  Johannes Kornhuber; Christian P Müller; Katrin Anne Becker; Martin Reichel; Erich Gulbins
Journal:  Trends Pharmacol Sci       Date:  2014-05-01       Impact factor: 14.819

Review 8.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

9.  Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+.

Authors:  Mikhail Strokin; Marina Sergeeva; Georg Reiser
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

10.  Immobilization stress alters intermediate metabolism and circulating lipoproteins in the rat.

Authors:  David Ricart-Jané; Victor Rodríguez-Sureda; Alex Benavides; Julia Peinado-Onsurbe; M Dolores López-Tejero; Miquel Llobera
Journal:  Metabolism       Date:  2002-07       Impact factor: 8.694

View more
  56 in total

1.  A Resting-State Functional MR Imaging and Spectroscopy Study of the Dorsal Hippocampus in the Chronic Unpredictable Stress Rat Model.

Authors:  Ricardo Magalhães; Ashley Novais; David A Barrière; Paulo Marques; Fernanda Marques; João C Sousa; João J Cerqueira; Arnaud Cachia; Therese M Jay; Michel Bottlaender; Nuno Sousa; Sébastien Mériaux; Fawzi Boumezbeur
Journal:  J Neurosci       Date:  2019-02-25       Impact factor: 6.167

Review 2.  Low Vs. High Alcohol: Central Benefits Vs. Detriments.

Authors:  Yousef Tizabi; Bruk Getachew; Clifford L Ferguson; Antonei B Csoka; Karl M Thompson; Alejandra Gomez-Paz; Jana Ruda-Kucerova; Robert E Taylor
Journal:  Neurotox Res       Date:  2018-01-04       Impact factor: 3.911

3.  Glucocorticoid receptor activation induces decrease of hippocampal astrocyte number in rats.

Authors:  Yu-Xia Lou; Jing Li; Zhen-Zhen Wang; Cong-Yuan Xia; Nai-Hong Chen
Journal:  Psychopharmacology (Berl)       Date:  2018-08-01       Impact factor: 4.530

4.  The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk.

Authors:  E E M Knowles; K Huynh; P J Meikle; H H H Göring; R L Olvera; S R Mathias; R Duggirala; L Almasy; J Blangero; J E Curran; D C Glahn
Journal:  Eur Psychiatry       Date:  2017-02-21       Impact factor: 5.361

Review 5.  Non-pharmacological factors that determine drug use and addiction.

Authors:  Serge H Ahmed; Aldo Badiani; Klaus A Miczek; Christian P Müller
Journal:  Neurosci Biobehav Rev       Date:  2018-09-01       Impact factor: 8.989

6.  Enriched Environment Enhances the Myelin Regulatory Factor by mTOR Signaling and Protects the Myelin Membrane Against Oxidative Damage in Rats Exposed to Chronic Immobilization Stress.

Authors:  Gangadharan Thamizhoviya; Arambakkam Janardhanam Vanisree
Journal:  Neurochem Res       Date:  2021-08-27       Impact factor: 3.996

7.  Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice.

Authors:  Shaye Kivity; Maria-Teresa Arango; Nicolás Molano-González; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

8.  Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats.

Authors:  Hongxin Dong; Jack M Keegan; Ellie Hong; Christopher Gallardo; Janitza Montalvo-Ortiz; Becky Wang; Kenner C Rice; John Csernansky
Journal:  Psychoneuroendocrinology       Date:  2018-02-19       Impact factor: 4.905

9.  Integrated metabolomics and lipidomics profiling of hippocampus reveal metabolite biomarkers in a rat model of chronic unpredictable mild stress-induced depression.

Authors:  Chunmei Geng; Yi Qiao; Yujin Guo; Wenxiu Han; Bin Wu; Changshui Wang; Jun Zhang; Dan Chen; Mengqi Yang; Pei Jiang
Journal:  Ann Transl Med       Date:  2019-12

10.  mRNA Expression of SMPD1 Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment.

Authors:  Cosima Rhein; Iulia Zoicas; Lena M Marx; Stefanie Zeitler; Tobias Hepp; Claudia von Zimmermann; Christiane Mühle; Tanja Richter-Schmidinger; Bernd Lenz; Yesim Erim; Martin Reichel; Erich Gulbins; Johannes Kornhuber
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.